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Abstract
Background: The transparency of the eye lens depends upon maintenance of the native state of the c- and b-crystallins,
which is aided by the abundant chaperones aA- and aB-crystallin. Mature onset cataract, the leading cause of blindness
worldwide, involves the polymerization of covalently damaged or partially unfolded crystallins into light-scattering
aggregates. A number of single amino acid substitutions and truncations of c-crystallins result in congenital cataract in both
humans and mice, though in many cases the coupling between the protein alterations and the accumulation of aggregates
is poorly defined.
Methodology/Principal Findings: We have studied the aggregation properties and chaperone interactions of human cD-
crystallin carrying substitutions of two buried core mutants, I90F and V75D, which cause congenital cataract in mice. The in
vitro aggregation pathway competing with productive refolding was not altered by either substitution. Furthermore, this
aggregation pathway for both mutant proteins–originating from a partially folded intermediate–was efficiently suppressed
by aB-crystallin. Thus the cataract pathology was unlikely to be associated with a direct folding defect. The native state of
wild-type human cD-crystallin exhibited no tendency to aggregate under physiological conditions. However both I90F and
V75D native-like proteins exhibited slow (days) aggregation to high molecular weight aggregates under physiological
conditions. The perturbed conformation of I90F was recognized and bound by both aA and aB chaperones. In contrast, the
aggregation derived from the perturbed state of V75D was not suppressed by either chaperone, and the aggregating
species were not bound by the chaperone.
Conclusions/Significance: The cataract phenotype of I90F in mice may be due to premature saturation of the finite a-
crystallin pool. The V75D aggregation pathway and its escape from chaperone surveillance and aggregation suppression
can account for the congenital cataract pathology of this mutant. Failure of chaperone recognition may be an important
source of pathology for many other protein folding defects.
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Introduction
Amino acid substitutions in diverse human proteins are
associated with a variety of pathologies. In some cases, these
reflect loss of the activity of the native state, for example, the
G551D and G1349D substitutions of CFTR result in aberrant
channel opening [1]. In other cases, such as the sickle cell
mutation and hemoglobin polymerization, they induce a poly-
meric, though native-like state resulting in the pathology [2]. In yet
other instances, substitutions may cause protein folding defects or
increased off-pathway aggregation. Examples include mutations in
transthyretin [3–5], lysozyme [6] and a1-antitrypsin [7,8].
However, for many mutant proteins our understanding of how
the substitution leads to the defect remains obscure. Given the
large number of proteins that require interaction with various
classes of chaperones, it seems likely that some defects classified as
protein stability or protein folding defects may reflect a failure to
be recognized by the appropriate chaperone. A well-characterized
example is the tumor suppressor VHL. The wild-type (WT)
protein is recognized by the group II chaperonin CCT; however,
CCT recognition of oncogenic mutants is altered [9].
Human cD-crystallin (HcD) is one of the three major c-
crystallins required for transparency of the human lens. It is
present in high concentrations in the lens nucleus, which is formed
in utero during early development. The terminally differentiated
lens fiber cells lack organelles including nuclei and ribosomes.
Thus, proteins synthesized prior to differentiation must maintain
their native structures and solubility over a lifetime. Cataract, the
leading cause of blindness worldwide, arises from the aggregation
of lens proteins resulting in opacification of the tissue.
While primarily a disease intimately linked with advanced age,
numerous cases of hereditary and congenital cataract in both
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genes [10–12]. The effects of a number of these amino acid
substitutions on the properties of the c-crystallins have been
studied in detail. Surface replacements of arginine residues
including R36S and R58H in HcD lowered the barrier to
crystallization resulting in rare crystal cataracts [13,14], rather
than the aggregated state found in mature onset cataracts. The
P23T HcD substitution altered solubility of the native state
[15,16]. Sandilands et al [17] showed that three different mouse
crystallin variants resulted in aggregation of the mutant proteins
within the lens fibers, and Moreau and King [18] reported
destabilization of HcD by buried core substitutions. Zhang et al
[19] found similar destabilization by the G61C substitution in
HcD. In cS-crystallin, the G18V substitution significantly
destabilized the native state [20]. However, studies of the
properties of the mutant proteins under chemical or thermal
stress do not account satisfactorily for the aggregation observed in
cataractous lenses under physiological conditions.
A fuller elucidation of the molecular mechanism of crystallin
aggregation is essential for understanding cataract formation and
for the development of prophylactics. Kosinski-Collins and King
used atomic force microscopy to image growing aggregates formed
upon dilution of denatured HcD into buffer [21]. While these
aggregates appeared fiber-like, they were not amyloid in nature
[21]. Further study of this aggregation pathway revealed that the
C-terminal domain (C-td) of HcD must be at least partially
unfolded for aggregation to proceed [22]. Molecular dynamics
simulations identified specific regions of the C-td that could serve
as nuclei for aggregation [23]. Oxidative damage to susceptible
side chains has been proposed as a major mechanism of protein
destabilization within the lens, but the coupling to aggregation is
not fully established [24–29]. Amyloid-like pathways have also
been reported for damaged or acid-treated proteins [17,30–32].
Recent evidence suggests that regions of the C-td of HcD are
responsible for amyloid formation [33].
The passive chaperone a-crystallin is also present at high
concentrations in the lens. Horwitz first showed that a-crystallin
possessed a strong molecular chaperone activity by suppressing the
thermal aggregation of the bovine bL- and c-crystallin fractions of
soluble lens protein [34]. It also suppressed the aggregation of a
range of other proteins including insulin, a-lactalbumin, apolipo-
protein C-II, citrate synthase, alcohol dehydrogenase and a-
synuclein [34–40]. With respect to its physiological substrates in
the lens, studies have demonstrated the ability of a-crystallin to
suppress bc-crystallin aggregation, including WT and deamidated
bB2 [41], truncated bB1 [27], and the major c-crystallins found in
human lenses [22]. The chaperone may also suppress the
aggregation of cytoskeletal proteins such as intermediate filaments
[42,43]. Several mutations in the a-crystallins are associated with
cataract in mice and humans [10]. Though both aA and aB are
present in the lens, only aA knockouts display a cataractous
phenotype [44,45].
As with many chaperones, a-crystallin does not bind the lens
crystallins in their native states [22,46], but appears to recognize
regions of partially unfolded or covalently damaged chains. Both
aA and aB bound destabilized mutant versions of b-crystallins
when incubated together, and this binding was correlated with the
population of an unfolding intermediate of mutant bB2-crystallin
[47]. Cataracts are very rare in humans below the age of about 50,
and this presumably reflects protection from protein aggregation
by a-crystallin. However, the a-crystallin pool is likely saturated in
older adults [48], so that the lens loses its capacity for chaperone
protection from protein damage and unfolding.
Here we present analyses of the aggregation behavior of WT
and mutant HcD proteins carrying the amino acid substitutions
V75D and I90F. These mutants represent substitutions in the
hydrophobic core of each double Greek Key domain. They are
associated with congenital cataract in mice [11,49] and were
previously found to destabilize HcD [18]. Recent studies indicated
that the double mutant I4F/V75D (known as I4F/V76D in [50])
sufficiently perturbed the protein conformation to enable a-
crystallin binding in the absence of aggregation [50].
Unfortunately, terminally differentiated primary lens fiber cells
cannot be maintained in cell culture, limiting studies to lens
epithelial cells or other cell types, where c-crystallins are not
normally found at high levels. Therefore, in vitro experiments were
performed to study two aggregation pathways. The first derives
from a partially folded intermediate associated with productive
refolding. It represents a model of misfolding that may occur
during the initial translation and folding events within the lens.
The second pathway results from a species derived from a
destabilized native-like state in the absence of denaturant. This
models destabilization and local or global unfolding that may
occur over time after translation and productive folding of the
mutant chains.
For some mutants, congenital cataract formation may represent
the destabilization and subsequent misfolding of the c- and b-
crystallins [20]. In other cases, mutations lead to alterations in
solubility while stability is maintained [13–16,51]. The results
reported here suggest that failure of a-crystallin to rescue altered
crystallin chains from aggregation is a likely contributor to cataract
for some congenital mutants, and may also contribute to mature
onset cataract.
Results
Wild-type and Mutant HcD Protein Aggregation
Compete with Refolding
Kosinski-Collins and King observed the aggregation of WT
HcD when rapidly diluted from the unfolded state in 5.5 M
guanidinium hydrochloride (GdnHCl) to buffer with residual
denaturant concentrations below 1 M [21]. This aggregation
pathway is in kinetic competition with the productive refolding
pathway of the protein. The aggregating polypeptide chains–
visualized by atomic force microscopy–first formed small globular
assemblies and then filamentous structures [21]. Based on
knowledge of the unfolding/refolding pathway of HcD, the
aggregation-prone intermediate species appeared to have a fully
unfolded N-terminal domain (N-td) and a partially unfolded or
otherwise destabilized C-td [22]. In particular, it was shown that
partial unfolding and population of the stable intermediate at
2.5 M GdnHCl did not result in appreciable aggregation upon
dilution to 0.5 M GdnHCl [22]. Instead, higher initial GdnHCl
concentrations were required. A similar prerequisite for aggrega-
tion was observed for the mutant proteins L5S, V75D and I90F
HcD [18].
To evaluate the partitioning of protein between the aggregation
and productive refolding pathways, we performed aggregation
assays for WT, V75D and I90F HcD. All proteins were denatured
in 5 M GdnHCl at 37uC and then diluted with buffer to initiate
refolding and competing aggregation. Solution turbidity was
monitored as the absorbance at 350 nm (A350) due to light
scattering by the growing aggregates. Changes in A350 were
essentially the same for WT and both mutant proteins (Figure 1A).
The A350 increased very quickly over the first ,2 minutes of the
reaction before reaching a maximum of about 1 AU for both the
WT and mutant proteins. The overall change in A350 was 0.31
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aggregation reaction was kinetically favored over refolding of HcD
to the native monomer. When chromatographed over a Superose
6 size exclusion chromatography (SEC) column, very little native
protein was recovered. Notably, high molecular weight (HMW)
species were absent at earlier elution volumes, indicating that the
aggregated species were too large to pass through a 0.2 mm
membrane filter and smaller oligomeric species were not present at
detectable levels (Figure 2, gray traces). Thus, this assay, which
monitors aggregation competing with refolding, did not detect
significant differences between the WT and mutant crystallins.
Suppression of HcD Aggregation by aB
Acosta-Sampson and King studied the chaperone activity of aB
against aggregation of three abundant human c-crystallins and
found that it differentially suppressed their aggregation [22].
Although the mutants discussed here appeared to aggregate
through a similar pathway–attested to by their similar aggregation
kinetics and overall levels of aggregation–it is possible that the
passive chaperone aB could interact with one or both of the
mutants in a different manner than with WT, resulting in a change
in aggregation kinetics or overall suppression levels. To this end,
aggregation suppression experiments were performed in the same
manner as the previously described assay, with the addition of a
5- fold molar excess of aB in the refolding buffer.
Under these conditions, aB suppressed the aggregation of the
WT and mutant proteins to similar extents (Figure 1B). The
maximum A350 for both WT and V75D was 0.27 AU, while that
of I90F was slightly higher at 0.31 AU. There was a slight increase
in solution turbidity over the time course of the experiment and no
initial burst in absorbance. The DA values were similar at ,0.07
for all three proteins in the presence of the chaperone (Table 1).
Based on the maximum A350 values, aB suppressed the
aggregation of WT HcD by 72%. In comparison, V75D
aggregation was suppressed by 73% and that of I90F by 70%.
Analysis of these suppression reactions by SEC resulted in the
separation of two distinct peaks (Figure 2, black traces). The first
peak eluted in the void volume and was composed of long-lived
complexes of aB and HcD. The second major peak corresponded
to excess chaperone and eluted in a broader peak around 13 ml.
The native HcD peak was minor in the case of WT and negligible
for both mutant proteins. These results are in agreement with
previous observations that the void volume peak contains protein
complexes [22]. As with the aggregation assay alone, the assay to
measure suppression of aggregation did not differentiate the
mutant proteins from the wild type.
Interactions of aB with Initially Native HcD
The suppression assays described above, which investigated the
in vitro refolding pathway and the competing aggregation pathway,
were conducted with HcD initially unfolded in 5 M GdnHCl.
Other aggregation pathways could originate from a native-like
state that may fluctuate and unfold over time, populating
conformations that may be aggregation-prone. Within the lens
we would not expect an unfolding pathway from the native state to
be the reverse of the folding pathway or aggregation pathway of
newly synthesized nascent chains released from ribosomes.
To address this, purified WT, V75D and I90F HcD were
incubated for 28 days at 37uC in the presence or absence of either
aAo raB. SEC was performed at 0, 14, 21, and 28 days to
determine whether soluble protein was lost to aggregation and/or
if the chaperones formed complexes with the WT or mutant
proteins. Samples were filtered before chromatography and large
aggregates were not detected with this method. As controls, each
protein, WT, V75D and I90F, was incubated individually, as were
aA and aB.
In control samples without chaperone, the levels of both WT
and mutant HcD proteins decreased over time, as shown by the
decreased peak size in later chromatograms (Figure 3). However,
the amplitude of the decrease was not the same across all proteins.
WT HcD had the least change in monomeric protein levels over
the course of the experiment. In the case of V75D, virtually no
protein peak was visible by SEC after 14 days of incubation and
white insoluble material was visible by eye. These aggregates could
be dissolved with 2% SDS and a prominent band at 20 kDa was
present upon SDS-PAGE analysis (see later Results). Smaller
fragments were not detected by gel electrophoresis, further
confirming that V75D was not proteolytically degraded during
the incubation. The recovery of I90F was intermediate and large-
scale aggregation was not observed as for V75D. aB was
unaffected by the prolonged incubation, while the elution volume
of aA was slightly earlier after incubation was complete (Figures 3
and 6, respectively).
Results of SEC for samples containing 1:1 mixtures of c- and
aB-crystallins are shown in Figure 4. For the mixture of WT HcD
and aB, no HMW complexes formed between the two proteins.
The aB peak remained unchanged over the course of the
experiment while the HcD peak broadened slightly. In the case
of V75D, the presence of aB did not affect aggregation (Figure 4).
Virtually all the soluble protein was lost after 14 days of incubation
and aggregates were again visible to the naked eye. HMW
complexes between aB and V75D were not present in SEC
separations and levels of aB did not decrease, indicating that it was
not incorporated into the visible aggregates. Based on these results,
V75D appears to aggregate through an intermediate not
recognized by aB. This could account for its cataractogenic
phenotype in the mouse.
In the case of I90F interacting with aB, after 14 days of
incubation at 37uC, samples separated by SEC contained HMW
complexes that eluted in the void volume of the column (Figure 4).
Individual peaks were still present for both native aB and I90F,
and growth of the complex peak in the void volume was observed
with concomitant decreases in both of the single protein peaks over
time. To verify that this complex peak contained both aB and
I90F, Western blots were performed to detect the presence of both
aB and HcD. Samples from fractions corresponding to the three
major peaks of the I90F + aB mixture (t=27 days) were analyzed.
Four fractions (13–16) corresponding to the complex peak were
analyzed (Figure 5A) and fractions 14 and 15 were most abundant
in I90F (Figure 5B). This confirmed that the long-lived complex
eluting in the void volume contained both a- and c-crystallin
proteins.
Interactions of aA with Initially Native HcD
In addition to aB, the a-crystallin multimers present in the lens
contain a significant proportion of aA. Interactions between the
native species were also evaluated for WT and mutant HcD with
aA to determine whether recognition patterns differed from those
of aB. Experiments were performed in the same manner as
described above.
Mixtures containing WT HcD and aA showed some evidence
of recognition and complex formation compared to aB. Early-
eluting complex peaks appeared in some instances and the major
aA peak appeared slightly shifted to an earlier elution time
(Figure 6). As in experiments with aB, a significant portion of WT
HcD remained soluble throughout the extended incubation times.
Upon mixing V75D with aA, V75D formed large insoluble
aggregates that were clearly visible by eye at 14 days. The SEC
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manner as well (Figure 6). Although in a minority of cases a peak
was observed in the void after 28 days, which was not the case with
aB, aA clearly did not inhibit the large-scale aggregation of V75D,
as shown by the loss of the V75D peak at ,19 ml. Finally,
mixtures of I90F with aA displayed similar behavior to those
containing aB. A growing peak appeared in the void volume over
time (Figure 6). As in the experiments with aB, a significant
portion of I90F remained soluble over time.
During the course of the 37uC incubation aA appeared to
undergo structural changes that resulted in a larger hydrodynamic
radius and earlier elution from the SEC column (Figure 6). Such
changes were not found for aB and did not appear to result from
the preheating of aA (see Materials and Methods), as protein
Figure 1. The aggregation of WT and mutant HcD in the absence and presence of aB. (A) Aggregation and (B) suppression reactions for
WT, V75D, and I90F HcD. Solution turbidity was monitored for 20 minutes to follow the formation of light-scattering aggregates upon rapid dilution
of HcD protein out of 5 M GdnHCl. For suppression reactions aB was present in a 5-fold molar excess in the dilution buffer. Each graph is labeled in its
upper right corner with the protein name.
doi:10.1371/journal.pone.0037256.g001
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respect.
The Chaperone-bound Conformation of I90F
To investigate the nature of the interaction between aB and
I90F described above, native mixing experiments were performed
using aB lacking tryptophans (W9F/W60F) to enable Trp
fluorescence measurement of the bound c-crystallin substrate
[22]. W9F/W60F-aB behaved like WT in terms of chaperone
activity [22] and did not aggregate over time when incubated
under native-like conditions (Figure 7A). Upon initial mixing,
there was no interaction between I90F and W9F/W60F-aB and
the proteins eluted separately from the SEC column. Following a
28-day incubation at 37uC, protein eluted in the void volume,
which corresponded to the complex of W9F/W60F-aB and I90F
(Figure 7A). This result is similar to that observed with WT aB and
further supports that the mutant W9F/W60F-aB maintains its
chaperone activity.
Tryptophan fluorescence was measured for fractions collected
from the 28-day samples to determine the general structural state
of the bound substrate. In fractions corresponding to the complex
peak, fluorescence was significantly higher than that of W9F/
W60F-aB in the absence of I90F (Figure 7B). This increased
fluorescence must therefore result from bound I90F molecules.
However, the fluorescence spectrum corresponds to neither the
native nor denatured states of I90F (Figure 7C). Instead, the lmax
is most similar to that of partially unfolded I90F, as observed in the
transition region of equilibrium unfolding curves [18].
The Aggregated State of V75D
Because V75D aggregated to near completion regardless of the
presence of a-crystallin, we set out to determine the nature of the
populated species along the aggregation pathway. Pellet/superna-
tant (P/S) fractionation was used to analyze the insoluble
aggregated material (Figure 8). Over time, soluble V75D in the
supernatant decreased while aggregated V75D increased in the
pellet. While the majority of aggregated V75D was dissociated to
the monomer upon treatment with SDS, a distinct dimeric species
was present in the pellet fraction on days 7 and 14, as well as small
proportions of putative trimeric and tetrameric species on day 14
(Figure 8). These species were resistant to dissociation by SDS + b-
ME, suggesting that the dimer is not stabilized by disulfide linkage,
or if so, that these linkages are buried and shielded from solvent,
even in the presence of SDS. The linkage may be mediated by the
aspartic acid introduced by way of mutation, or alternatively,
while not directly involved in the covalent chemistry, it may
increase the kinetics of a reaction that occurs more slowly in the
WT protein. The dimeric species may act as a so-called covalent
Table 1. Solution Turbidity Measurements for WT and Mutant
HcD in the Absence and Presence of aB.
Protein DA
1,2 Maximum A350
1
2 aB + aB 2 aB + aB
WT 0.3160.05 0.0660.01 0.9460.1 0.2760.06
V75D 0.3660.04 0.0660.01 1.060.05 0.2760.08
I90F 0.3560.05 0.0760.01 1.160.1 0.3160.04
1Units are Absorbance Units (AU) and means 6 standard deviations are given.
2DA = maximum A350 – minimum A350.
doi:10.1371/journal.pone.0037256.t001
Figure 2. Size exclusion chromatograms of aggregation and
suppression samples. Aggregation is shown in gray and aggregation
suppression is shown in black, with the suppression samples containing
a 5-fold excess of aB. Each chromatogram is labeled in its upper right
corner with the protein name.
doi:10.1371/journal.pone.0037256.g002
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is non-covalent and thus disrupted in the presence of SDS.
Discussion
The physiologically relevant disturbances in protein confor-
mation that lead to aggregation of lens bc-crystallins have been
difficult to elucidate. Oxidative damage, such as conversion of
glutamines to glutamates, reduces the stability of both the b- and
c- crystallins, but it is not clear that these reductions are sufficient
to generate aggregation under native in vivo conditions [24–
26,41]. The I90F and V75D substitutions in cD-crystallin cause
congenital cataracts in mice [11,49]. However, the mutant
proteins fold efficiently within E. coli, and refold in vitro under
specific conditions, making it unlikely that they represent direct
folding defects [18]. Finet and colleagues reported that oxida-
tively damaged b-crystallins exhibited reduced binding by a-
crystallin [41]. We therefore examined more carefully two
aggregation pathways as well as their suppression by a-crystallin
chaperones.
Refolding-induced Aggregation Follows the Same
Pathway in Both WT and Mutant HcD
For HcD, upon dilution from high concentrations of GdnHCl,
the partially folded protein followed an aggregation pathway in
kinetic competition with productive refolding. The majority of
molecules in solution were incorporated into amorphous aggre-
gates. Both partially folded V75D and I90F chains aggregated to
the same extent as WT HcD. Light-scattering curves had the same
shape and intensity. This indicated that the reactions proceeded
through the same intermediate as for WT and that population of
this conformation was not affected by either mutation. If it were, a
change in light scattering levels would have been expected.
Alternatively, the mutant proteins could have aggregated through
a different intermediate, but overall aggregate size and protein
incorporation were similar.
Similarly, levels of aggregation suppression by aB were
comparable to those observed for WT. This would be expected
if the intermediates recognized by aB were the same for WT and
both mutants. Because aB recognizes a range of proteins, it is
reasonable that it could bind alternative conformations of these c-
Figure 3. Size exclusion chromatograms of single protein controls for native mixing experiments. Separate samples were prepared for
each time point in SEC buffer. In all cases proteins were present at 1 mg/ml. Each chromatogram is labeled in its upper left corner with the protein
name.
doi:10.1371/journal.pone.0037256.g003
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ed that the C-td of both the WT and mutant proteins must be
partially unfolded for aggregation to occur, making it likely that
the same species was recognized by aB in all cases.
aB effectively suppressed the aggregation of its physiological
substrate in experiments where HcD was initially unfolded. The
ratio of cD:aB for these experiments was 1:5, the optimal ratio for
suppression determined by Acosta-Sampson and King [22]. The
high ratio of aB was required due to the rapid aggregation under
these conditions. Lower ratios were successfully used for proteins
whose aggregation proceeded at significantly slower rates [52].
Given the duplicated domains of the crystallins, and the
presence of intermediates which have an exposed face of a
normally buried domain interface, domain swapping is an
appealing model for aggregation [53]. Substitutions at the domain
interface decreased stability [54–56], making exposure more likely.
The chaperone may be recognizing the exposed face of one
domain, or perhaps an interface between the Greek keys. In
another protein deposition disease, light chain amyloidosis,
destabilization of the immunogloublin variable domain b-sheet
increased amyloidicity, perhaps by a domain swapping mechanism
[57,58].
Defective Recognition by a-crystallin Suggests Different
Mechanisms of Cataract Formation
In contrast to suppression of aggregation competing with
refolding, native-like mutant cD-crystallins exhibited altered
interactions with a-crystallin chaperones. WT HcD incubated in
buffer at 37uC remained highly soluble over weeks, in agreement
with the long extrapolated half-time for the unfolding of WT HcD
in the absence of denaturant [59]. While HMW complex
formation with aA and aB was minimal, some interaction with
aA was detected. These interactions could indicate the transient
unfolding of a small population of WT molecules, possibly owing
to the in vitro nature of these experiments.
In contrast to WT, V75D spontaneously aggregated within 7
days and little protein remained in the native monomeric state.
This pathway presumably derives from a conformer of the
destabilized native-like state, as distinct from the intermediates
populated in the refolding protocol. In vivo observations by Wang
et al. showed that nuclear and cytoplasmic aggregates were formed
in the mouse lens expressing the murine cD mutant [60].
Neither aA nor aB had a significant effect on the aggregation of
V75D. These results are supported by 2-D gel analysis of lens
proteins from mice expressing V76D cD. Although the mutant
protein was enriched in the water-insoluble fraction of lens
protein, levels of soluble a-crystallin were unchanged among WT
and hetero- or homozygous mutant lens [60]. The agreement
between these results emphasizes that the in vitro experiments may
serve as suitable models for biochemical analysis of protein
stability and protein-protein interactions within the lens, especially
considering the lack of lens fiber cell culture.
The substitution could result in local unfolding or could allow
hydrophobic core exposure through small changes in backbone
conformation. These may not provide recognition sites for the
chaperone. An alternative explanation is that the introduction of a
charged side chain disrupts a hydrophobic region that would
otherwise serve as a binding site for a-crystallin, while the overall
intermediate conformation is maintained.
Either case might result in formation of the covalently linked
dimer found in V75D aggregates. The linkage may be mediated
through the introduced aspartate side chain, or the mutation may
increase the rate of formation of the dimer by making other
reactive groups more accessible. Overall, this suggests that in the
Figure 4. Size exclusion chromatograms of native protein
mixtures containing WT or mutant HcD and aB chaperone.
Separate samples were prepared for each time point in SEC buffer.
Times given are in days. In all cases proteins were present at 1 mg/ml.
Each chromatogram is labeled in its upper left corner with the protein
mixture.
doi:10.1371/journal.pone.0037256.g004
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37256Figure 5. Western Blot analysis of I90F + aB native mixing. (A) Size exclusion chromatograms of the I90F + aB mixture after a 27 day
incubation at 37uC. The shaded areas represent the fractions that were analyzed by Western Blot. (B) Two Western Blots were performed on identical
sets of samples. The upper panel detected the presence of aB and the lower panel detected HcD. Numbers along the bottom are SEC fractions.
Fractions 13–16 comprised the complex peak; fractions 23–25 comprised the aB peak; fractions 35–37 comprised the I90F peak.
doi:10.1371/journal.pone.0037256.g005
Figure 6. Size exclusion chromatograms of native protein mixtures containing WT or mutant HcD and aA chaperone. Separate
samples were prepared for each time point in SEC buffer. Times given are in days. In all cases proteins were present at 1 mg/ml. Each chromatogram
is labeled in its upper left corner with the protein mixture.
doi:10.1371/journal.pone.0037256.g006
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crystallin and form light-scattering aggregates.
When incubated alone, native I90F gradually accumulated
aggregated material over the 28-day period. In the presence of
either aAo raB, I90F formed a HMW complex with the
chaperone whose population increased over time. The slow
decrease of I90F monomers with time, in opposition to V75D,
suggests the gradual unfolding and population of an aggregation-
prone species. This makes I90F an ideal target for sequestration by
the components of a-crystallin.
Other studies have confirmed that a-crystallin is a better
chaperone of slower aggregation processes [37,61] supporting this
interpretation. A similar interaction with bovine a-crystallin was
observed for I4F murine cB-crystallin in in vitro mixing experi-
ments at elevated temperatures [62]. In lens extracts from mice
harboring this mutation, a complex was formed between a-
crystallin and c- crystallins, presumably the I4F mutant [62].
While analogous behavior in vivo would prevent the growth of
large aggregates of I90F, the finite supply of a-crystallin could
become saturated with mutant protein molecules more quickly
than in the normal lens. This would impede further chaperone
activity and likely compromise other interactions, such as those
with lenticular cytoskeletal proteins [42,63,64].
Recent findings by Mchaourab and colleagues complement
those for V75D described here. In particular, they observed that
under native conditions, the protein does not interact with aAo r
Figure 7. Analysis of native mixing for I90F and W9F/W60F-aB. (A) Size exclusion chromatograms of I90F + W9F/W60F-aB mixtures upon
initial mixing (0 days) and after the 28-day incubation at 37uC. W9F/W60F-aB alone is shown for comparison. (B) Tryptophan fluorescence comparison
of WT aB (dashed line) and W9F/W60F-aB (solid line). Proteins were present at 0.05 mg/ml. (C) Comparison of tryptophan fluorescence for native I90F
(open circles), denatured I90F (open squares), I90F equilibrated in 1.7 M GdnHCl, the transition midpoint of unfolding (open triangles), and I90F in
complex with W9F/W60F-aB (solid black line).
doi:10.1371/journal.pone.0037256.g007
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does the chaperone recognize its substrate [50]. However, they did
not observe appreciable formation of HMW complexes between
a-crystallin and the substrates investigated [50].
In essence, our results are in agreement with the model
proposed by Mishra et al [50] in that unfolding of the C-td triggers
recognition and suppression of aggregation by the chaperone.
V75D, though significantly destabilized in the N-td, populates a
conformation whose aggregation is not suppressed presumably
because its C-td is not sufficiently denatured. The HMW
complexes that elute in the void volume correspond to chaper-
one-bound substrate with compromised C-td stability and/or
structure. This conclusion is also supported by studies on the
fluorescence properties of bound substrates by Acosta-Sampson
and King [22].
Point mutations in HcD resulting in single amino acid
substitutions lead to very different causes of cataract. The well
characterized P23T and R58H substitutions dramatically reduce
protein solubility [14,16,51,65,66]. R14C results in disulfide-
mediated aggregation [67] and R36S increases the propensity for
crystallization [13,14]. The work presented here expands on how
the destabilizing mutations V75D and I90F may result in cataract
disease. In particular, these results support the proposal that
multiple mechanisms may lead to cataract formation and these
biochemical analyses can provide initial models of in vivo events.
Materials and Methods
Cloning, Protein Expression and Purification
WT HcD and mutant proteins V75D and I90F were prepared
as previously described [18]. Both WT and W9F/W60F-aB were
expressed and purified as previously described [22]. WT aA was
expressed similarly and purified following procedures modified
from [52]. Two rounds of anion exchange chromatography were
performed. In the first round, aA was pooled from the sample
flow-through. This was re-applied to the column and eluted in a
step gradient of 10%, 25%, and 100% B (Buffer A: 50 mM Tris,
pH 8.0; Buffer B: 50 mM Tris, 1 M NaCl, pH 8.0). Ion
exchange was followed by size exclusion chromatography in
50 mM sodium phosphate, 150 mM NaCl, pH 7.0, using a
Superose 6 10/300 GL column (GE Healthcare, Piscataway, NJ).
Protein concentrations were determined by UV absorbance at
280 nm using the following extinction coefficients:
42,860 M
21 cm
21 (WT, V75D and I90F HcD),
14,440 M
21 cm
21 (aA) and 13,980 M
21 cm
21 (aB). Extinction
coefficients were calculated using ExPASy ProtParam [68]. The
concentration of W9F/W60F-aB was measured using the BCA
assay (Pierce, Rockford, IL).
Aggregation and Suppression of Aggregation
Assays were based on the protocols of Acosta-Sampson and
King [22]. WT and mutant HcD proteins at 1 mg/ml were
unfolded by incubating overnight at 37uC in 5 M GdnHCl,
100 mM sodium phosphate, 1 mM EDTA, 5 mM DTT, pH 7.0.
Unfolded protein was placed in a quartz cuvette and diluted 10-
fold with refolding buffer (100 mM sodium phosphate, 1 mM
EDTA, 5 mM DTT, pH 7.0) to achieve final concentrations of
0.1 mg/ml HcD and 0.5 M GdnHCl. Samples were mixed by
rapidly pipetting upon addition of buffer. Solution turbidity (A350)
was measured continuously for 20 minutes, beginning immediately
after sample mixing. Aggregation suppression assays were
performed in the same manner, with the addition of aB in the
refolding buffer at a final concentration of 0.5 mg/ml. Cuvette
temperature was maintained at 37uC using a single cell Peltier
controller and all protein and buffer solutions were maintained at
37uC during the experiments. Experiments with each protein were
performed at least in triplicate.
Native Interaction Assays
Each of the HcD proteins, WT, V75D and I90F, were mixed
with either aAo raB in a 1:1 ratio at concentrations of 1 mg/ml in
SEC buffer. For samples containing aA, the chaperone was
preheated at 42uC for 15 minutes prior to sample preparation.
Samples were then incubated in a 37uC warm room with constant
gentle rotation for up to 28 days. At various time points, samples
were removed, filtered through a 0.2 mm membrane, and applied
Figure 8. Supernatant (S)/pellet (P) fractionations of WT and V75D incubations at selected time points. Lanes are: M, marker with
relevant molecular weights noted in kDa; 1, WT-S t=0d; 2, WT-P t=0d; 3, V75D-S t=0d; 4, V75D-P t=0d; 5, WT-S t=8d; 6, WT-P t=8d; 7, V75D-S
t=7d; 8, V75D-P t=7d; 9, WT-S t=15d; 10, WT-P t=15d; 11, V75D-S t=14d; 12, V75D-P t=14d. WT samples were analyzed on days 8 and 15, while
V75D samples were analyzed on days 7 and 14.
doi:10.1371/journal.pone.0037256.g008
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every 0.5 ml and SDS-PAGE samples were reduced and boiled
immediately following separation for further analysis. Fractions
were assessed for formation of a:c complexes, as well as for
changes in free a and free c peaks. Control samples were prepared
containing either aAo raB only, or the individual HcD proteins,
each at 1 mg/ml, and treated identically to experimental mixtures.
Experimental mixing samples were prepared and analyzed at least
in triplicate and controls were prepared and analyzed in duplicate
or triplicate.
0.5 ml fractions collected from native interaction sample
separations were electrophoresed through 14% SDS-PAGE gels
and proteins were transferred to 0.2 mm pore size PVDF
membranes (Millipore, Billerica, MA). Sets of identical mem-
branes were probed with primary antibodies for aB and HcD
(Santa Cruz Biotechnology, Santa Cruz, CA). Alkaline phospha-
tase-conjugated secondary antibodies were used in conjunction
with the Immun-Blot colorimetric assay (Bio-Rad, Hercules, CA)
for signal detection.
Identical native mixing assays were performed using W9F/
W60F-aB and I90F HcD. Samples were filtered and applied to a
Superose 6 10/300 GL column at 0 and 28 days post-mixing.
0.5 ml fractions were collected. The Trp fluorescence was
measured for the fractions corresponding to the aB:cD complex,
free aB and free HcD to determine the conformation of I90F
when bound by aB. Measurements were taken with a Hitachi F -
4500 fluorescence spectrophotometer using the following param-
eters: lex=300 nm; lem=310–400 nm; excitation and emission
bandwidths =10 nm; scan rate =60 nm/min.
P/S separations were used to analyze the partitioning of V75D
protein over time. Samples containing 1 mg/ml V75D (native
mixing control samples) were incubated as described above. After
0, 7–8 and 14–15 days aggregates were pelleted by centrifugation
at 10,0006g for 20 minutes at 4uC. Supernatants were carefully
removed, reduced and boiled with SDS sample buffer. The pellets
were washed twice with SEC buffer. Pelleted material was
resolubilized by boiling in sample buffer containing 2% SDS
and b-ME. Samples were electrophoresed through 14% poly-
acrylamide gels and Coomassie stained. WT HcD incubated over
the same time period was used as a control and treated identically.
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